Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study.

The Lancet regional health. Europe·2026

Same author

Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol.

Contemporary clinical trials·2026

Same author

Very short-term monitoring of Romosozumab longitudinal effects in a cohort of postmenopausal women by means of Radiofrequency Echographic Multi-Spectrometry (REMS) technology.

Aging clinical and experimental research·2026

Same author

Anthropometric Indices and Markers of Atherothrombotic Risk in Subjects with Primary Hyperparathyroidism.

Metabolites·2026

Same author

Lifestyle Intervention Therapy Modulates Global DNA Methylation and Adipogenic Gene Expression in Severely Obese Hypogonadal Men.

Metabolites·2026

Same author

Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences.

The Journal of clinical endocrinology and metabolism·2026

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Estrogen hydroxylation in osteoporosis.

Nicola Napoli¹, Reina Armamento-Villareal

¹Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.

Advances in Clinical Chemistry

|January 26, 2007

Summary

Estrogen metabolism pathways influence bone mineral density (BMD) in postmenopausal women. Genetic variations in CYP450 enzymes affect estrogen hydroxylation, impacting osteoporosis risk and hormone replacement therapy response.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Experiment Videos

Last Updated: Jul 17, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Area of Science:

Endocrinology
Genetics
Bone Metabolism

Background:

Estrogen metabolism occurs via 2-hydroxyl (nonestrogenic) and 16alpha-hydroxyl (estrogenic) pathways.
These pathways significantly influence bone mineral density (BMD) in postmenopausal women.
Predominant 2-hydroxylation is linked to accelerated bone loss and lower BMD, while 16alpha-hydroxylation offers protection.

Purpose of the Study:

To investigate the role of estrogen metabolism pathways and CYP450 gene polymorphisms in determining BMD.
To explore the association between estrogen metabolism patterns and osteoporosis risk.
To examine the implications of estrogen hydroxylation patterns for response to estrogen/hormone replacement therapy (ERT/HRT).

Main Methods:

Analysis of estrogen metabolism pathways (2-hydroxyl vs. 16alpha-hydroxyl).
Investigation of cytochrome P450 (CYP450) enzyme polymorphisms, including CYP1A1 C4887A.
Correlation of genetic variations and metabolic profiles with BMD and osteoporosis risk.

Main Results:

Women with predominant 2-hydroxylation exhibit lower BMD and accelerated bone loss.
A positive family history of osteoporosis correlates with increased 2-hydroxylation.
The CYP1A1 C4887A polymorphism (A allele) is associated with lower BMD and faster estrogen hydroxylation.

Conclusions:

Inherited differences in estrogen metabolism, influenced by CYP450 polymorphisms, contribute to osteoporosis risk.
Estrogen hydroxylation patterns are critical determinants of individual BMD and response to ERT/HRT.
Genetic and metabolic profiling may enable personalized prediction of ERT/HRT efficacy.